Silvia Alberti Violetti

ORCID: 0000-0001-7163-1035
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous lymphoproliferative disorders research
  • Lymphoma Diagnosis and Treatment
  • Fungal Infections and Studies
  • Nail Diseases and Treatments
  • Autoimmune Bullous Skin Diseases
  • T-cell and Retrovirus Studies
  • CAR-T cell therapy research
  • CNS Lymphoma Diagnosis and Treatment
  • Urticaria and Related Conditions
  • Mast cells and histamine
  • Vascular Tumors and Angiosarcomas
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Toxin Mechanisms and Immunotoxins
  • Psoriasis: Treatment and Pathogenesis
  • melanin and skin pigmentation
  • Asthma and respiratory diseases
  • Dermatological diseases and infestations
  • Dermatology and Skin Diseases
  • Autoimmune and Inflammatory Disorders
  • PI3K/AKT/mTOR signaling in cancer
  • Viral-associated cancers and disorders
  • Dermatological and Skeletal Disorders
  • Systemic Lupus Erythematosus Research
  • Dermatological and COVID-19 studies

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2015-2024

University of Milan
2014-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2019-2024

Ospedale Maggiore
2016-2024

John Wiley & Sons (United States)
2023

Hudson Institute
2023

John Wiley & Sons (United Kingdom)
2023

Liechtenstein Institute
2023

Oxfam
2023

European Organisation for Research and Treatment of Cancer
2018

Julia Scarisbrick Pietro Quaglino H. Miles Prince Evangelia Papadavid Emmilia Hodak and 95 more M. Bagot Octavio Servitje Emilio Berti Pablo L. Ortiz‐Romero Rudolf Stadler Aikaterini Patsatsi Robert Knobler Emmanuella Guenova Fiona Child Sean Whittaker Vasiliki Nikolaou Carlo Tomasini Iris Amitay Hadas Prag Naveh C. Ram‐Wolff Maxime Battistella Silvia Alberti Violetti R. Stranzenbach Vanessa Gargallo Cristina Muniesa Triantafyllia Κoletsa Constanze Jonak Stefanie Porkert Christina Mitteldorf Teresa Estrach Andrea Combalía Márta Marschalkó Judit Csomor Ágota Szepesi Antonio Cozzio Reinhard Dummer Nicola Pimpinelli Vieri Grandi M. Beylot‐Barry Anne Pham‐Ledard Marion Wobser Eva Geissinger Ulrike Wehkamp Michael Weichenthal Richard Cowan Eileen Parry Jeremy P. Harris Rachel Wachsmuth Deborah Turner Andrew Bates Eugene Healy Franz Trautinger Johanna Latzka Jungmin Yoo B. Vydianath Rasoul Amel-Kashipaz Leonidas Marinos A. Oikonomidi Alexander J. Stratigos Marie‐Dominique Vignon‐Pennamen Maxime Battistella Fina Climent Eva González‐Barca Elisavet Georgiou Rebecca Senetta Pier Luigi Zinzani Liisa Väkevä Annamari Ranki A.M. Busschots Esther Hauben An Bervoets F. J. Sherida H. Woei‐A‐Jin Rubeta Matin Graham P. Collins Sophie Weatherhead J. Frew M. Bayne Giles Dunnill Pam McKay Arvind Arumainathan Richard Azurdia Kim Benstead Robert Twigger Kerri E. Rieger Ryanne A. Brown José Antônio Sanches Denis Miyashiro Oleg E. Akilov Sue McCann Helka Sahi Fabiana Damasco Christiane Querfeld Amy Folkes Cecilia Bur C.‐D. Klemke Paula Enz Ramón M. Pujol Koen D. Quint Larisa J. Geskin Eric Hong

Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study a web-based data collection system for early-stage MF with legal data-sharing agreements permitting international collaboration rare cancer complex pathology. Clinicopathological must 100% complete in-built intelligence the database ensures accurate staging.

10.1111/bjd.17258 article EN British Journal of Dermatology 2018-09-29

This guideline has been initiated by the task force Autoimmune Blistering Diseases of European Academy Dermatology and Venereology, including physicians from all relevant disciplines patient organizations. It is a S3 consensus-based that systematically reviewed literature on mucous membrane pemphigoid (MMP) in MEDLINE EMBASE databases until June 2019, with no limitations language. While first part this addressed methodology, as well epidemiology, terminology, aetiology, clinical presentation...

10.1111/jdv.17395 article EN cc-by-nc Journal of the European Academy of Dermatology and Venereology 2021-07-26

Abstract This guideline on mucous membrane pemphigoid (MMP) has been elaborated by the Task Force for Autoimmune Blistering Diseases of European Academy Dermatology and Venereology (EADV) with a contribution physicians from all relevant disciplines patient organizations. It is S3 consensus‐based encompassing systematic review literature until June 2019 in MEDLINE EMBASE databases. first part covers methodology, clinical definition MMP, epidemiology, MMP subtypes, immunopathological...

10.1111/jdv.17397 article EN Journal of the European Academy of Dermatology and Venereology 2021-07-10

Mycosis fungoides (MF) and Sézary Syndrome (SS) are the most common cutaneous T-cell lymphomas. MF/SS is accompanied by considerable morbidity from pain, itching disfigurement.To identify factors associated with poorer health-related quality of life (HRQoL) in patients newly diagnosed MF/SS.Patients enrolled into Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI; an international observational study MF/SS) had their HRQoL assessed using Skindex-29 questionnaire. scores...

10.1111/bjd.18089 article EN British Journal of Dermatology 2019-05-03

Pustular and erythrodermic psoriasis are rare difficult-to-treat conditions. It has recently been shown that interleukin (IL)-17 inhibitors can be very effective among patients with these forms of psoriasis; however, the potential IL-23 is largely unknown. The aim this multicentre, retrospective study was to compare safety, effectiveness, drug survival IL-17 affected by psoriasis. involved 27 59 pustular (36 generalised 23 palmoplantar psoriasis) treated an or inhibitor. effectiveness two...

10.3390/jcm12041662 article EN Journal of Clinical Medicine 2023-02-19

The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a prospective analysis of an international database. Here we examine front-line treatments and quality life (QoL) in patients with newly diagnosed mycosis fungoides (MF).

10.1111/bjd.19252 article EN British Journal of Dermatology 2020-06-01

Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma (CD4+ PCSM-TCL) is a rare lymphoproliferative disorder with favorable prognosis. Distinguishing it from other lymphomas often challenge.We retrospectively collected CD4+PCSM-TCL cases two centers (MD Anderson Cancer Center, USA and University of Milan, Italy) evaluated their clinicopathological features. Array-comparative genomic hybridization (aCGH) analysis was performed on 11 cases.A total 62 patients were identified....

10.1111/cup.12806 article EN Journal of Cutaneous Pathology 2016-08-23

Primary cutaneous lymphomas are neoplasms of the immune system with a distinct tropism for skin and an absence extracutaneous manifestations at time diagnosis. Studies focusing on in children adolescents remain scarce often do not encompass rare subtypes.

10.1111/jdv.20028 article EN cc-by-nc-nd Journal of the European Academy of Dermatology and Venereology 2024-04-23

Background/ Objectives: Melanoma is the most severe form of skin cancer, with incidence increasing worldwide. However, there still a lack strong evidence to support melanoma screening, and screening strategies vary among healthcare systems. This study aims compare effectiveness two strategies, total-body (TBS) examination lesion-directed (LDE) suspicious lesion, in detecting at earlier stages (thickness<0.8mm). Methods: Data was collected from all patients who came for dermatology...

10.20944/preprints202502.0200.v1 preprint EN 2025-02-04

The term "Primary Cutaneous B-Cell Lymphoma" (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by clonal proliferation B-cells primarily involving the skin. absence evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have completely different clinical behavior and prognosis. In this article, we summarized clinico-pathological features main...

10.4103/ijd.ijd_74_17 article EN cc-by-nc-sa Indian Journal of Dermatology 2017-01-01

Background Topical chlormethine (CL) is recommended as a first-line treatment for early-stage mycosis fungoides (MF) and in 2017, the European Medicines Agency approved CL gel formulation to treat adult patients. More recently, increase patient compliance adherence, clinicians have developed flexible protocols that allow concomitant use of with topical corticosteroids daily practice regimens. Therefore, sharing real-life data on side effects management may help improve this agent. Objectives...

10.3389/fonc.2023.1298296 article EN cc-by Frontiers in Oncology 2024-01-04

Abstract Background Lymphomatoid papulosis (LyP) is a rare cutaneous T-cell lymphoproliferative disorder. Comprehensive data on LyP in the paediatric population are scarce. Objectives To characterize epidemiological, clinical, histopathological and prognostic features of LyP. Methods This was retrospective multicentre international cohort study that included 87 children adolescents with diagnosed between 1998 2022. Patients aged ≤ 18 years at disease onset were included. diagnosis made each...

10.1093/bjd/ljae150 article EN cc-by-nc British Journal of Dermatology 2024-04-09

Primary cutaneous acral CD8 + T‐cell lymphoma (acral TCL ) is a new provisional entity characterized by skin lesions and an indolent course. We describe extraordinary case relapsed nodules with cytotoxic infiltrates on the left ear. After 35 years, spread to other sites, mass same histological features as appeared nose. Multiple courses of chemotherapy led stable disease. Histological examinations carried out at different times showed gradual transformation neoplastic cells, increased...

10.1111/cup.13020 article EN Journal of Cutaneous Pathology 2017-08-10
Coming Soon ...